V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 320005142 | 320003503 | 1.74 | null | Palliative (P) | 2015-07-22 | 2016-05-23 | Liposomal Doxorubicin 40mg/m2 | N | N | 320015752 | LIPOSOMAL DOXORUBICIN |
| 320005143 | 320003503 | 1.79 | 59 | Curative (C) | 2018-03-13 | 2018-04-05 | Cisplatin + Radiotherapy | N | N | 320015752 | CISPLATIN + RT |
| 320005144 | 320003504 | 1.56 | 73 | Curative (C) | 2014-02-01 | 2014-02-02 | Cisplatin | 2 | N | 320015758 | CISPLATIN |
| 320005147 | 320003506 | null | 65 | Curative (C) | 2014-04-22 | 2014-04-26 | CISPLATIN + RT | null | null | 320015783 | CISPLATIN + RT |
| 320005148 | 320003506 | 1.72 | 79 | Palliative (P) | 2018-12-30 | 2018-12-30 | Liposomal Doxorubicin (Caelyx) | N | N | 320015783 | LIPOSOMAL DOXORUBICIN |
| 320005149 | 320006595 | 1.62 | 103 | Adjuvant (A) | 2016-04-05 | 2016-05-01 | CISPLATIN + RT | 2 | N | 320015798 | CISPLATIN + RT |
| 320005150 | 320003507 | 1.77 | null | Palliative (P) | 2013-08-01 | 2013-08-22 | CISPLATIN + FLUOROURACIL | N | N | 320015801 | CISPLATIN + FLUOROURACIL |
| 320005151 | 320003507 | 1.64 | null | Curative (C) | 2013-11-09 | 2013-12-03 | Cisplatin 100 + RT(H&N) 1 day | 02 | null | 320015801 | CISPLATIN + RT |
| 320005152 | 320003509 | 1.49 | 74 | Palliative (P) | 2016-09-15 | 2016-09-16 | Trial Unspecified | N | null | 320015806 | TRIAL |
| 320005153 | 320007069 | 1.78 | 51.9 | Palliative (P) | 2016-04-27 | 2016-11-06 | Carboplatin + Liposomal Doxorubicin | 1 | N | 320015815 | CARBOPLATIN + LIPOSOMAL DOX |
| 320005154 | 320003514 | 1.64 | 84.2 | null | 2014-12-12 | 2014-12-17 | Trial Unspecified | Y | null | 320015830 | TRIAL |
| 320005155 | 320003515 | null | 68 | Curative (C) | 2017-11-06 | 2017-12-18 | Cisplatin + Radiotherapy | N | Y | 320015838 | CISPLATIN + RT |
| 320005158 | 320003517 | 0 | 66 | Curative (C) | 2017-10-26 | 2017-11-03 | Carboplatin + Liposomal Doxorubicin | Y | N | 320015848 | CARBOPLATIN + LIPOSOMAL DOX |
| 320005159 | 320003521 | 1.88 | 120 | Palliative (P) | 2018-04-19 | 2018-04-28 | Liposomal Doxorubicin 50mg/m2 | Y | N | 320015851 | LIPOSOMAL DOXORUBICIN |
| 320005160 | 320003523 | 1.62 | 56.5 | Curative (C) | 2014-01-22 | 2014-02-21 | CISPLATIN + RT | 2 | Y | 320015858 | CISPLATIN + RT |
| 320005161 | 320003523 | 1.74 | 101 | Curative (C) | null | 2014-07-25 | Cisplatin + Radiotherapy | null | null | 320015858 | CISPLATIN + RT |
| 320005162 | 320003525 | 1.65 | 72.4 | Curative (C) | 2016-12-06 | 2017-01-17 | Cisplatin + Radiotherapy | N | N | 320015862 | CISPLATIN + RT |
| 320005163 | 320006598 | 1.78 | 66.9 | Curative (C) | 2014-04-12 | 2014-05-10 | Cisplatin 100 + RT(H&N) 1 day | N | Y | 320015863 | CISPLATIN + RT |
| 320005164 | 320006598 | 1.71 | 24.6 | Palliative (P) | 2015-12-24 | 2016-04-19 | Cisplatin +Fluorouracil (3 wk) | N | N | 320015863 | CISPLATIN + FLUOROURACIL |
| 320005165 | 320003526 | null | 72 | Palliative (P) | 2018-01-19 | 2018-02-16 | GEMCARBO | N | Y | 320015874 | GEMCARBO |
| 320005166 | 320003526 | 1.62 | null | Neo-adjuvant (N) | 2016-09-10 | 2016-10-07 | CETUXIMAB | N | N | 320015874 | CETUXIMAB |
| 320005167 | 320003528 | 1.6 | 57.3 | Curative (C) | 2018-04-03 | 2018-04-04 | Cisplatin + Radiotherapy | N | N | 320015888 | CISPLATIN + RT |
| 320005168 | 320005605 | 1.68 | 43.8 | Palliative (P) | 2018-03-01 | 2018-12-28 | GemCarbo Days 1+8 | 02 | null | 320015891 | GEMCARBO |
| 320005169 | 320003529 | 1.72 | 98 | Palliative (P) | 2015-06-30 | 2015-09-20 | Cisplatin | N | N | 320015892 | CISPLATIN |
| 320005170 | 320003530 | 1.62 | 77 | Palliative (P) | 2017-04-22 | 2017-04-22 | Liposomal Doxorubicin (Caelyx) | 02 | null | 320015893 | LIPOSOMAL DOXORUBICIN |
| 320005171 | 320003531 | 1.71 | 79.7 | Palliative (P) | 2013-10-26 | 2013-10-31 | null | 02 | N | 320015896 | NOT MATCHED |
| 320005172 | 320003532 | 1.56 | 49 | null | 2018-01-06 | 2018-02-03 | Cisplatin + Radiotherapy | 02 | N | 320015906 | CISPLATIN + RT |
| 320005173 | 320005606 | 1.6 | 71.1 | Palliative (P) | null | 2018-09-08 | Liposomal Doxorubicin (Caelyx) | N | N | 320015911 | LIPOSOMAL DOXORUBICIN |
| 320005174 | 320003533 | 1.63 | 76.8 | Palliative (P) | 2017-06-17 | 2017-06-17 | Liposomal Doxorubicin (Caelyx) | N | null | 320015912 | LIPOSOMAL DOXORUBICIN |
| 320005175 | 320003535 | 1.72 | 79.4 | Palliative (P) | 2018-02-01 | 2018-02-27 | Liposomal Doxorubicin (Caelyx) | 02 | N | 320015922 | LIPOSOMAL DOXORUBICIN |
| 320005176 | 320003537 | 1.87 | 65.4 | Neo-adjuvant (N) | 2016-12-28 | 2017-01-11 | CISPLATIN + FLUOROURACIL | N | N | 320015925 | CISPLATIN + FLUOROURACIL |
| 320005177 | 320003539 | 1.66 | 64.7 | Palliative (P) | 2016-10-16 | 2017-04-30 | GEMCARBO | 99 | N | 320015930 | GEMCARBO |
| 320005178 | 320005607 | 1.5 | 14.2 | Palliative (P) | 2013-08-10 | 2013-09-05 | CISPLATIN + FLUOROURACIL | N | N | 320015931 | CISPLATIN + FLUOROURACIL |
| 320005179 | 320005607 | 1.66 | 81.3 | Neo-adjuvant (N) | 2016-07-04 | 2016-07-30 | CISPLATIN + FLUOROURACIL | N | N | 320015931 | CISPLATIN + FLUOROURACIL |
| 320005181 | 320003541 | 1.8 | null | Neo-adjuvant (N) | 2017-05-30 | 2017-05-30 | Trial Unspecified | 2 | N | 320015940 | TRIAL |
| 320005182 | 320003541 | 1.72 | 88.1 | Palliative (P) | 2016-01-03 | 2016-01-10 | Trial Unspecified | N | N | 320015940 | TRIAL |
| 320005183 | 320003541 | 1.72 | 85.6 | Palliative (P) | 2014-10-27 | 2015-08-15 | Liposomal Doxorubicin (Caelyx) | N | N | 320015940 | LIPOSOMAL DOXORUBICIN |
| 320005184 | 320003544 | 1.65 | 81 | Palliative (P) | 2016-05-05 | 2016-05-09 | GEMCARBO | 02 | N | 320015952 | GEMCARBO |
| 320005185 | 320003545 | 1.64 | 73 | Adjuvant (A) | 2014-08-28 | 2014-09-04 | CISPLATIN + RT | N | Y | 320015975 | CISPLATIN + RT |
| 320005186 | 320003546 | 1.52 | 57.8 | Adjuvant (A) | 2016-02-07 | 2016-02-11 | GemCarbo Days 1+8 | N | N | 320015976 | GEMCARBO |
| 320005187 | 320005609 | 1.57 | 53.6 | Adjuvant (A) | 2018-06-06 | 2018-09-28 | Cisplatin + Radiotherapy | Y | N | 320015981 | CISPLATIN + RT |
| 320005188 | 320003547 | 1.55 | 69.7 | Palliative (P) | 2014-08-29 | 2015-03-20 | CARBOPLATIN + GEMCITABINE | N | Y | 320015989 | GEMCARBO |
| 320005189 | 320003548 | 1.77 | 78.2 | Adjuvant (A) | 2015-11-01 | 2015-12-17 | Cisplatin + Radiotherapy | 02 | N | 320015989 | CISPLATIN + RT |
| 320005190 | 320003548 | 1.67 | 52.25 | Palliative (P) | 2015-11-04 | 2015-11-17 | Cetuximab 7 day (>Cycle 2) | N | N | 320015989 | CETUXIMAB |
| 320005191 | 320003549 | 1.71 | 61.8 | Palliative (P) | 2018-02-21 | 2018-02-25 | Cetuximab 7 day (>Cycle 2) | Y | N | 320016035 | CETUXIMAB |
| 320005192 | 320003550 | null | 50 | Palliative (P) | 2015-06-21 | 2015-06-27 | Liposomal Doxorubicin 50mg/m2 | N | N | 320016044 | LIPOSOMAL DOXORUBICIN |
| 320005193 | 320003552 | null | 86 | Palliative (P) | 2015-11-01 | 2015-11-01 | Carboplatin + Liposomal Doxorubicin | N | N | 320016054 | CARBOPLATIN + LIPOSOMAL DOX |
| 320005194 | 320003553 | null | 79.4 | Palliative (P) | 2017-03-08 | 2017-03-09 | CARBOPLATIN + GEMCITABINE | N | null | 320016065 | GEMCARBO |
| 320005195 | 320003556 | 1.52 | 68.3 | Palliative (P) | 2017-03-07 | 2017-03-10 | GemCarbo Days 1+8 | N | N | 320016065 | GEMCARBO |
| 320005196 | 320003557 | null | 81 | Curative (C) | 2016-06-01 | 2016-08-04 | Cisplatin + Radiotherapy | N | N | 320016072 | CISPLATIN + RT |